Removal of polycyclic synthetic musks and antineoplastic drugs in ozonated wastewater: Quantitation based on the data of differential spectroscopy

Journal of Hazardous Materials

Volumn 304, Issue , 2016, Pages 242-250

  Li, Wei ^a   Nanaboina, Venkateswarlu ^b   Chen, Fang ^c   Korshin, Gregory V ^d  

^a NANJING FORESTRY UNIVERSITY   (China)

^b Pashmylaram   (India)

^c NORTHEASTERN UNIVERSITY AT QINHUANGDAO   (China)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Absorbance spectra; Antineoplastic drugs; Effluent organic matter (EfOM); Ozonation; Polycyclic musk

Indexed keywords

BIOGEOCHEMISTRY; BIOLOGICAL MATERIALS; DRUG PRODUCTS; FREE RADICALS; ORGANIC COMPOUNDS; OZONE; OZONE WATER TREATMENT; OZONIZATION; PHOTODEGRADATION; RATE CONSTANTS;

ABSORBANCE SPECTRUM; ANTINEOPLASTIC DRUGS; DIFFERENTIAL SPECTROSCOPY; DISSOLVED ORGANIC MATTERS; EFFLUENT ORGANIC MATTER; MUNICIPAL WASTEWATERS; NON-LINEAR CORRELATIONS; POLYCYCLIC MUSKS;

EFFLUENTS;

4 CHLOROBENZOIC ACID; ANTINEOPLASTIC AGENT; BUSULFAN; CELESTOLIDE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DACARBAZINE; DISSOLVED ORGANIC MATTER; FLUTAMIDE; GALAXOLIDE; HYDROXYL RADICAL; IFOSFAMIDE; METHOTREXATE; MUSK; ORGANIC MATTER; OZONE; PHANTOLIDE; POLYCYCLIC HYDROCARBON; POLYCYCLIC MUSK; TAMOXIFEN; TONALIDE; TRASEOLIDE; UNCLASSIFIED DRUG; BENZOPYRAN DERIVATIVE; INDAN DERIVATIVE; OXIDIZING AGENT; TETRALIN DERIVATIVE; WASTE WATER; WATER POLLUTANT;

ABSORBANCE; DATA ACQUISITION; DISSOLVED ORGANIC MATTER; DRUG; EFFLUENT; ORGANIC MATTER; OXIDATION; OZONE; PAH; POLLUTANT REMOVAL; RADICAL; SPECTROSCOPY; SPECTRUM; WASTEWATER;

ABSORPTION; ARTICLE; DEGRADATION; EFFLUENT; MASS SPECTROMETRY; MOLECULAR MODEL; OXIDATION; OZONATION; WASTE COMPONENT REMOVAL; WASTE WATER; WASTE WATER MANAGEMENT; CHEMISTRY; PROCEDURES; SEWAGE; WATER POLLUTANT;

ANTINEOPLASTIC AGENTS; BENZOPYRANS; INDANS; OXIDANTS; OZONE; TETRAHYDRONAPHTHALENES; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84946550187     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2015.10.035     Document Type: Article

References (52)

1. Ellis J.B. Pharmaceutical and personal care products (PPCPs) in urban receiving waters. Environ. Pollut. 2006, 144(1):184-189.
2. Jjemba P.K. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol. Environ. Saf. 2006, 63(1):113-130.
3. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43(2):363-380.
4. Santos L.H.M.L.M., Araújo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C.B.S.M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175(1-3):45-95.
5. Shon H.K., Vigneswaran S., Snyder S.A. Effluent organic matter (EfOM) in wastewater: constituents, effects and treatment. Crit. Rev. Environ. Sci. Technol. 2006, 36(4):327-374.
6. Lee I., Lee S., Oh J. Occurrence and fate of synthetic musk compounds in water environment. Water Res. 2010, 44(1):214-222.
7. Clara M., Gans O., Windhofer G., Krenn U., Hartl W., Braun K., Scharf S., Scheffknecht C. Occurrence of polycyclic musks in wastewater and receiving water bodies and fate during wastewater treatment. Chemosphere 2011, 82(8):1116-1123.
8. Homem V., Silva J.A., Ratola N., Santos L., Alves A. Long lasting perfume-a review of synthetic musks in WWTPs. J. Environ. Manag. 2015, 149:168-192.
9. Rimkus G.G. Polycyclic musk fragrances in the aquatic environment. Toxicol. Lett. 1999, 111(1-2):37-56.
10. Peck A.M., Hornbuckle K.C. Synthetic musk fragrances in Lake Michigan. Environ. Sci. Technol. 2004, 38(2):367-372.
11. Chase D.A., Karnjanapiboonwong A., Fang Y., Cobb G.P., Morse A.N., Anderson T.A. Occurrence of synthetic musk fragrances in effluent and non-effluent impacted environments. Sci. Total Environ. 2012, 416:253-260.
12. Peck A.M., Hornbuckle K.C. Synthetic musk fragrances in urban and rural air of Iowa and the Great Lakes. Atmos. Environ. 2006, 40(32):6101-6111.
13. Rimkus G.G., Wolf M. Polycyclic musk fragrances in human adipose tissue and human milk. Chemosphere 1996, 33(10):2033-2043.
14. Duedahl-Olesen L., Cederberg T., Pedersen K.H., Hojgard A. Synthetic musk fragrances in trout from Danish fish farms and human milk. Chemosphere 2005, 61(3):422-431.
15. Hutter H.P., Wallner P., Moshammer H., Hartl W., Sattelberger R., Lorbeer G., Kundi M. Blood concentrations of polycyclic musks in healthy young adults. Chemosphere 2005, 59(4):487-492.
16. Parolini M., Magni M., Traversi I., Villa S., Finizio A., Binelli A. Environmentally relevant concentrations of galaxolide (HHCB) andtonalide (AHTN) induced oxidative and genetic damage in Dreissena polymorpha. J. Hazard. Mater. 2015, 285:1-10.
17. Besse J., Latour J., Garric J. Anticancer drugs in surface waters what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?. Environ. Int. 2012, 39(1):73-86.
18. Zhang J., Chang V.W.C., Giannis A., Wang J.Y. Removal of cytostatic drugs from aquatic environment: a review. Sci. Total Environ. 2013, 445-446:281-298.
19. Zounkova R., Odraska P., Dolezalova L., Hilscherova K., Marsalek B., Blaha L. Ecotoxicity and genetoxicity assessment of cytostatic pharmaceuticals. Environ. Toxicol. Chem. 2007, 26(10):2208-2214.
20. Kovacs R., Csenki Z., Bakos K., Urbanyi B., Horvath A., Garaj-Vrhovac V., Gajski G., Geri M., Negreira N., Lopez de Alda M., Barcelo D., Heath E., Kosjek T., Zegura B., Novak M., Zajc I., Baebler S., Rotter A., Ramsak Z., Filipic M. Assessment of toxicity and genotoxicity of low doses of 5-fluorouracil in zebrafish (Danio rerio) two-generation study. Water Res. 2015, 77:201-212.
21. Orias F., Bony S., Devaux A., Durrieu C., Aubrat M., Hombert T., Wigh A., Perrodin Y. Tamoxifen ecotoxicity and resulting risks for aquatic ecosystem. Chemosphere 2015, 128:79-84.
22. Llewellyn N., Lloyd P., Jurgens M.D., Johnson A.C. Determination of cyclophosphamide and ifosfamide in sewage effluent by stable isotope-dilution liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2011, 1218(47):8519-8528.
23. Kosjek T., Heath E. Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. Trends Anal. Chem. 2011, 30(7):1065-1087.
24. Rowney N.C., Johnson A.C., Williams R.J. Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the thames catchment in the united kingdom. Environ. Toxicol. Chem. 2009, 28(12):2733-2743.
25. Gooding M.P., Newton T.J., Bartsch M.R., Hornbuckle K.C. Toxicity of synthetic musks to early life stages of the freshwater mussel Lampsilis cardium. Arch. Environ. Contam. Toxicol. 2006, 51(4):549-558.
26. Zounkova R., Kovalova L., Blaha L., Dott W. Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites. Chemosphere 2010, 81(2):253-260.
27. Chen C., Zhou Q., Liu S., Xiu Z. Acute toxicity, biochemical and gene expression responses of the earthworm Eisenia fetida exposed to polycyclic musks. Chemosphere 2011, 83(8):1147-1154.
28. Von Gunten U. Ozonation of drinking water: part I. Oxidation kinetics and product formation. Water Res. 2003, 37(7):1443-1467.
29. 2 Advanced Oxidation Process 2012, Wate Reuse Foundation, Alexandria, VA.
30. Godayol A., Gonzalez-Olmos R., Sanchez J.M., Anticó E. Assessment of the effect of UV and chlorination in the transformation of fragrances in aqueous samples. Chemosphere 2015, 125:25-32.
31. Wombacher W.D., Hornbuckle K.C. Synthetic musk fragrances in a conventional drinking water treatment plant with lime softening. J. Environ. Eng. 2009, 135(11):1192-1198.
32. Roig B., Marquenet B., Delpla I., Bessonneau V., Sellier A., Leder C., Thomas O., Bolek R., Kuemmerer K. Monitoring of methotrexate chlorination in water. Water Res. 2014, 57:67-75.
33. Li W., Tanumihardja J., Masuyama T., Korshin G.V. Examination of the kinetics of degradation of the antineoplastic drug 5-fluorouracil by chlorine and bromine. J. Hazard. Mater. 2015, 282:125-132.
34. Esplugas S., Bila D.M., Krause L.G., Dezotti M. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. J. Hazard. Mater. 2007, 149(3):631-642.
35. Ternes T.A., Stuber J., Herrmann N., McDowell D., Ried A., Kampmann M., Teiser B. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?. Water Res. 2003, 37(8):1976-1982.
36. Santiago-Morales J., Gomez M.J., Herrera S., Fernandez-Alba A.R., Garcia-Calvo E., Rosal R. Oxidative and photochemical processes for the removal of galaxolide and tonalide from wastewater. Water Res. 2012, 46(14):4435-4447.
37. Molinos-Senante M., Reif R., Garrido-Baserba M., Hernandez-Sancho F., Omil F., Poch M., Sala-Garrido R. Economic valuation of environmental benefits of removing pharmaceutical and personal care products from WWTP effluents by ozonation. Sci. Total Environ. 2013, 461-462:409-415.
38. Garcia-Ac A., Broseus R., Vincent S., Barbeau B., Prevost M., Sauve S. Oxidation kinetics of cyclophosphamide and methotrexate by ozone in drinking water. Chemosphere 2010, 79(11):1056-1063.
39. Dickenson E.R., Drewes J.E., Sedlak D.L., Wert E.C., Snyder S.A. Applying surrogates and indicators to assess removal efficiency of trace organic chemicals during chemical oxidation of wastewater. Environ. Sci. Technol. 2009, 43(16):6242-6247.
40. Wert E.C., Rosario-Ortiz F.L., Snyder S.A. Using ultraviolet absorbance and color to assess pharmaceutical oxidation during ozonation of wastewater. Environ. Sci. Technol. 2009, 43(13):4858-4863.
41. Nanaboina V., Korshin G.V. Evolution of absorbance spectra of ozonated wastewater and its relationship with the degradation of trace-level organic species. Environ. Sci. Technol. 2010, 44(16):6130-6137.
42. Gerrity D., Gamage S., Jones D., Korshin G.V., Li Y., Pisarenko A., Trenholm R.A., von Gunten U., Wert E., Snyder S.A. Development of surrogate correlation models to predict trace organic contaminant oxidation during ozonation. Water Res. 2012, 46(19):6257-6272.
43. Kubwabo C., Fan X., Rasmussen P.E., Wu F. Determination of synthetic musk compounds in indoor house dust by gas chromatography-ion trap mass spectrometry. Anal. Bioanal. Chem. 2012, 404(2):467-477.
44. http://www.chemspider.com.
45. Booker V., Halsall C., Llewellyn N., Johnson A., Williams R. Prioritising anticancer drugs for environmental monitoring and risk assessment purposes. Sci. Total Environ. 2014, 473-474:159-170.
46. APHA Standard methods for the examination of water and wastewater 1995, American Public Health Association, Washington, DC. 19th ed.
47. Li W., Nanaboina V., Zhou Q., Korshin G. Effects of Fenton treatment on the properties of effluent organic matter and their relationships with the degradation of pharmaceuticals and personal care products. Water Res. 2012, 46(2):403-412.
48. Liu C., Nanaboina V., Korshin G.V., Jiang W.J. Spectroscopic study of degradation products of ciprofloxacin, norfloxacin and lomefloxacin formed in ozonated wastewater. Water Res. 2012, 46(16):5235-5246.
49. Liu C., Nanaboina V., Korshin G. Spectroscopic study of the degradation of antibiotics and the generation of representative EfOM oxidation products in ozonated wastewater. Chemosphere 2012, 86(8):774-782.
50. Janzen N., Dopp E., Hesse J., Richards J., Turk J., Bester K. Transformation products and reaction kinetics of fragrances in advanced wastewater treatment with ozone. Chemosphere 2011, 85(9):1481-1486.
51. Yao C.C.D., Haag W.R. Rate constants for direct reactions of ozone with several drinking water contaminants. Water Res. 1991, 25(7):761-773.
52. Huber M.M., Canonica S., Park G.-Y., von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 2006, 37(5):1016-1024.